This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of CONTRAVE ER 8-90 mg tablets in quantities of 120 per container. The contract has a ceiling value of $17,368.57 and spans from the award date of September 25, 2024 through the ultimate completion date of September 26, 2024. This award is a delivery order under a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for supplying a range of medical commodities to military treatment programs and facilities worldwide. The contract does not have a set-aside designation.
Generated 12/25/24, 9:17 AM